Stockreport

Revance Highlights Recent Regulatory Progress and Provides Anticipated 2019 Milestones

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF - Completes Type B Pre-BLA meeting with U.S. FDA for glabellar lines indication and remains on track to submit application in first half of 2019 - [Read more]